Raïs-Bahrami K, Rivera O, Mikesell G T, Seale W R, Sell J E, Short B L
Department of Neonatology, Children's National Medical Center, Washington, DC 20010, USA.
Crit Care Med. 1995 Oct;23(10):1722-5. doi: 10.1097/00003246-199510000-00017.
To determine whether modifications of the original design of a double-lumen, venovenous, extracorporeal membrane oxygenation (ECMO) catheter would reduce recirculation and improve oxygenation during venovenous ECMO.
Prospective, interventional study.
The animal research laboratory at The Children's National Medical Center.
Six newborn lambs, 1 to 7 days old and weighing 4.7 +/- 0.9 kg.
Animals were anesthetized, intubated and ventilated. The ductus arteriosus was ligated. Femoral artery and vein, cephalic jugular vein, and pulmonary artery catheters were placed. After systemic heparinization, the test catheter (with venous drainage holes moved away from the arterial return holes) was placed in the right internal jugular vein and advanced into the right atrium. The animal was placed on ECMO and stabilized, with the ventilator settings decreased to a peak inspiratory pressure of 15 cm H2O, peak positive end-expiratory pressure of 5 cm H2O, respiratory rate of 15 breaths/min, and an FIO2 of 0.21. ECMO flows were increased in 100-mL increments from 200 to 600 mL/min, with measurements taken 15 mins after each change. The test catheter was removed, the double-lumen, venovenous ECMO catheter was placed, and the studies were repeated.
Heart rate, mean arterial pressure, PaO2, jugular cerebral oxygen saturation, pulmonary artery oxygen saturation, mixed venous oxygen saturation, and postmembrane circuit pressures were measured at each study period. The test catheter improved oxygenation significantly, with higher systemic PaO2, higher pulmonary artery and cerebral oxygen saturations, and lower mixed venous oxygen saturations (indicating less recirculation). With the test catheter, PaO2 levels ranged from 62 +/- 6 torr (8.3 +/- 0.8 kPa) to 112 +/- 12 torr (14.9 +/- 1.6 kPa), compared with 46 +/- 4 torr (6.1 +/- 0.5 kPa) to 59 +/- 2 torr (7.9 +/- 0.3 kPa) for the double-lumen, venovenous ECMO catheter (p < or = .001). These findings indicate that at all flow rates studied, less recirculation occurred with the test catheter than with the double-lumen, venovenous ECMO catheter.
These findings indicate that the redesign of the double-lumen, venovenous ECMO catheter, as outlined in this study, resulted in a significant reduction of recirculation, thereby resulting in a significant improvement in oxygenation while on venovenous ECMO. This newly designed catheter makes venovenous ECMO more effective, and represents a design that could be used for pediatric and/or adult ECMO.
确定双腔静脉 - 静脉体外膜肺氧合(ECMO)导管原始设计的改良是否会减少静脉 - 静脉ECMO期间的再循环并改善氧合。
前瞻性干预研究。
儿童国家医疗中心的动物研究实验室。
6只1至7日龄、体重4.7±0.9千克的新生羔羊。
动物麻醉、插管并通气。结扎动脉导管。放置股动脉和静脉、颈静脉和肺动脉导管。全身肝素化后,将测试导管(静脉引流孔远离动脉回血孔)置于右颈内静脉并推进至右心房。动物置于ECMO上并稳定,呼吸机设置降低至吸气峰压15 cm H2O、呼气末正压峰压5 cm H2O、呼吸频率15次/分钟、吸入氧分数0.21。ECMO流量以100 mL增量从200增加至600 mL/分钟,每次变化后15分钟进行测量。移除测试导管,放置双腔静脉 - 静脉ECMO导管,并重复研究。
在每个研究阶段测量心率、平均动脉压、动脉血氧分压(PaO2)、颈静脉脑氧饱和度、肺动脉氧饱和度、混合静脉氧饱和度和膜后回路压力。测试导管显著改善了氧合,全身PaO2更高、肺动脉和脑氧饱和度更高、混合静脉氧饱和度更低(表明再循环更少)。使用测试导管时,PaO2水平范围为62±6托(8.3±0.8千帕)至112±12托(14.9±1.6千帕),而双腔静脉 - 静脉ECMO导管为46±4托(6.1±0.5千帕)至59±2托(7.9±0.3千帕)(p≤0.001)。这些发现表明,在所有研究的流量下,测试导管的再循环比双腔静脉 - 静脉ECMO导管少。
这些发现表明,本研究中概述的双腔静脉 - 静脉ECMO导管的重新设计显著减少了再循环,从而在静脉 - 静脉ECMO期间显著改善了氧合。这种新设计的导管使静脉 - 静脉ECMO更有效,代表了一种可用于儿科和/或成人ECMO的设计。